Buy Crypto Markets Spot FuturesZEC Earn Event Centre Rewards Hub

Aspire Biopharma Holdings, Inc. (ASBP)

NASDAQ

$8,83

$--

(0,00%)

Pre-Market

Aspire Biopharma Holdings, Inc. (ASBP) Live Price Chart

Last updated: ⁦2026-09-09 10:17:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Aspire Biopharma Holdings, Inc. (ASBP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $8,83, with a market capitalisation of $12,44M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3,31 to $566,76. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$12,44M
Open	$8,83
Day's High	$35.088,00
Day's Low	$3,31
Previous Close	$8,85
Volume	81,00
Average Volume	271,73K
P/E Ratio	--
52-Week High	$566,76
52-Week Low	$3,31
Dividend Yield	--
Earnings Date	--

Aspire Biopharma Holdings, Inc. (ASBP) Pre-Market Stock Price

Aspire Biopharma Holdings, Inc. (ASBP) is trading at $8,83 in pre-market trading as of 2026-09-09 10:10:00, down 0,23% ($0,02) from the previous close of $8,85

Pre-market trading shows how investors are pricing ASBP before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Aspire Biopharma Holdings, Inc. (ASBP) 7-Day Stock Price Change

Over the past seven days, Aspire Biopharma Holdings, Inc. (ASBP) moved from $8,51 to $8,83, representing a gain of 3,76% ($0,32).

The stock traded between $8,07 and $9,50 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 31,66 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ASBP 52-Week Price Position

Position in Range: 1,0%

52W Low$3,31

52W High$566,76

ASBP is currently trading at $8,83, placing it 1,0% of the way from its 52-week low of $3,31 to its 52-week high of $566,76. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Aspire Biopharma Holdings, Inc. (ASBP)?

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Aspire Biopharma Holdings, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Exchange	NASDAQ
Company Website	https://www.aspirebiolabs.com

How to Buy Aspire Biopharma Holdings, Inc. (ASBP) Stock on MEXC

Eligible investors can buy real shares of Aspire Biopharma Holdings, Inc. (ASBP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ASBP and Place Your Order

Open the RealStocks trading page and search for ASBP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Aspire Biopharma Holdings, Inc. (ASBP) share price today?

Aspire Biopharma Holdings, Inc. (ASBP) is currently trading at $ 8,83, down 0,23% ($0,02) from the previous close of $ 8,85. Intraday prices update in real time during regular trading hours.

2.Is ASBP stock going up or down today?

As of 2026-09-09 10:10:00, ASBP is trading at $ 8,83, down 0,23% ($0,02) from its previous close of $ 8,85. The stock has traded between $ 3,31 and $ 35.088,00 during today’s regular session. Past price movements do not guarantee future results.

3.What is ASBP pre-market price?

As of 2026-09-09 10:10:00, ASBP is trading at $ 8,83 in pre-market trading, down 0,23% ($0,02) from the previous close of $ 8,85. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ASBP after-hours price?

As of 2026-09-09 10:10:00, ASBP is trading at $ 8,83 in after-hours trading, down 0,23% ($0,02) from the regular-session close of $ 8,85. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is ASBP stock trading now?

ASBP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ASBP sit relative to its 52-week high and low?

Over the past 52 weeks, ASBP has traded between a low of $ 3,31 and a high of $ 566,76. At $ 8,83, the stock is positioned 1,0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Aspire Biopharma Holdings, Inc. in?

Aspire Biopharma Holdings, Inc. (ASBP) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Aspire Biopharma Holdings, Inc.'s market capitalisation and where is it listed?

Aspire Biopharma Holdings, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 12,44M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ASBP valued in terms of P/E ratio and EPS?

ASBP trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -7,88. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Aspire Biopharma Holdings, Inc. pay a dividend?

Aspire Biopharma Holdings, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.